Literature DB >> 26089283

Delayed bleeding and hemorrhage of mucosal defects after gastric endoscopic submucosal dissection on second-look endoscopy.

Shoko Ono1, Masayoshi Ono2, Manabu Nakagawa3, Yuichi Shimizu2, Mototsugu Kato3, Naoya Sakamoto2.   

Abstract

BACKGROUND: Although second-look endoscopy is performed within several days after gastric endoscopic submucosal dissection (ESD), there has been no evidence supporting the usefulness of the intervention. We investigated the relationship between delayed bleeding and hemorrhage of mucosal defects after ESD on second-look endoscopy and analyzed risk factors of active bleeding on second-look endoscopy.
METHODS: A total of 441 consecutive ESD cases with gastric cancer or adenoma were retrospectively analyzed. Second-look endoscopy was performed in the morning after the day of ESD. Bleeding of mucosal defects on second-look endoscopy was classified according to the Forrest classification, and active bleeding was defined as Forrest Ia or Ib. Delayed bleeding was defined as hematemesis or melena after second-look endoscopy.
RESULTS: A total of 406 second-look endoscopies were performed, and delayed bleeding occurred in 11 patients. The incidence rate of delayed bleeding after second-look endoscopy in patients with Forrest Ia or Ib was significantly higher than that in patients with Forrest IIa, IIb or III (7.69 vs. 2.02 %, p < 0.05). Complication of a histological ulcer, large size of the resected specimen and long ESD procedure time were shown to be risk factors for hemorrhage of mucosal defects after ESD on second-look endoscopy by univariate analysis. Multivariate analysis indicated that only large size of the resected specimen was a risk factor. In a specimen size of >35 mm, the odds ratio of active bleeding on second-look endoscopy was 1.9.
CONCLUSION: Active bleeding of mucosal defects on second-look endoscopy is a risk factor for delayed bleeding.

Entities:  

Keywords:  Endoscopic gastrointestinal surgery; Gastric cancer; Postoperative hemorrhage

Mesh:

Year:  2015        PMID: 26089283     DOI: 10.1007/s10120-015-0507-y

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  20 in total

1.  Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions.

Authors:  Tatsuya Toyokawa; Tomoki Inaba; Shizuma Omote; Akiko Okamoto; Rika Miyasaka; Kazuo Watanabe; Koichi Izumikawa; Joichiro Horii; Isao Fujita; Shigenao Ishikawa; Tamiya Morikawa; Takako Murakami; Jun Tomoda
Journal:  J Gastroenterol Hepatol       Date:  2012-05       Impact factor: 4.029

2.  Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection--an analysis of risk factors.

Authors:  K Takizawa; I Oda; T Gotoda; C Yokoi; T Matsuda; Y Saito; D Saito; H Ono
Journal:  Endoscopy       Date:  2008-03       Impact factor: 10.093

3.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Authors:  Shiro Oka; Shinji Tanaka; Iwao Kaneko; Ritsuo Mouri; Mayuko Hirata; Toru Kawamura; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2006-09-20       Impact factor: 9.427

4.  Outcomes and predictive factors of "not self-completion" in gastric endoscopic submucosal dissection for novice operators.

Authors:  Shouko Ono; Mototsugu Kato; Manabu Nakagawa; Aki Imai; Keiko Yamamoto; Yuichi Shimizu
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

5.  Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by osaka university ESD study group.

Authors:  Tomofumi Akasaka; Tsutomu Nishida; Shusaku Tsutsui; Tomoki Michida; Takuya Yamada; Hideharu Ogiyama; Shinji Kitamura; Makoto Ichiba; Masato Komori; Osamu Nishiyama; Fumihiko Nakanishi; Shinichiro Zushi; Akihiro Nishihara; Hideki Iijima; Masahiko Tsujii; Norio Hayashi
Journal:  Dig Endosc       Date:  2011-01       Impact factor: 7.559

6.  A multicenter retrospective study of endoscopic resection for early gastric cancer.

Authors:  Ichiro Oda; Daizo Saito; Masahiro Tada; Hiroyasu Iishi; Satoshi Tanabe; Tsuneo Oyama; Toshihiko Doi; Yoshihide Otani; Junko Fujisaki; Yoichi Ajioka; Tsutomu Hamada; Haruhiro Inoue; Takuji Gotoda; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

7.  Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis.

Authors:  Ho Yoel Ryu; Jae Woo Kim; Hyun-Soo Kim; Hong Jun Park; Hyo Keun Jeon; So Yeon Park; Bo Ra Kim; Cui Cui Lang; Sung Ho Won
Journal:  Gastrointest Endosc       Date:  2013-03-24       Impact factor: 9.427

8.  Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesions.

Authors:  Kotaro Mannen; Seiji Tsunada; Megumi Hara; Kanako Yamaguchi; Yasuhisa Sakata; Takehiro Fujise; Takahiro Noda; Ryo Shimoda; Hiroyuki Sakata; Shinichi Ogata; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-09-17       Impact factor: 7.527

9.  A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding.

Authors:  Osamu Goto; Mitsuhiro Fujishiro; Shinya Kodashima; Satoshi Ono; Keiko Niimi; Kousuke Hirano; Nobutake Yamamichi; Kazuhiko Koike
Journal:  Gastrointest Endosc       Date:  2009-11-17       Impact factor: 9.427

10.  Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers?

Authors:  W Heldwein; J Schreiner; J Pedrazzoli; P Lehnert
Journal:  Endoscopy       Date:  1989-11       Impact factor: 10.093

View more
  7 in total

1.  Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection?

Authors:  Kimihiro Igarashi; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Masao Yoshida; Sayo Ito; Kenichiro Imai; Kinichi Hotta; Hirotoshi Ishiwatari; Hiroyuki Matsubayashi; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2016-08-16       Impact factor: 4.584

2.  Different clinical characteristics associated with acute bleeding and delayed bleeding after endoscopic submucosal dissection in patients with early gastric cancer.

Authors:  Takafumi Yano; Satoshi Tanabe; Kenji Ishido; Mizuto Suzuki; Natsuko Kawanishi; Sakiko Yamane; Akinori Watanabe; Takuya Wada; Mizutomo Azuma; Chikatoshi Katada; Wasaburo Koizumi
Journal:  Surg Endosc       Date:  2017-04-04       Impact factor: 4.584

3.  Transarterial embolisation for gastroduodenal bleeding following endoscopic resection.

Authors:  Suyoung Park; Boryeong Jeong; Ji Hoon Shin; Eun Ho Jang; Jung Han Hwang; Jeong Ho Kim
Journal:  Br J Radiol       Date:  2021-04-16       Impact factor: 3.629

4.  Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification.

Authors:  Jong Yeul Lee; Chan Gyoo Kim; Soo-Jeong Cho; Young-Il Kim; Il Ju Choi
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

5.  Efficacy of second-look endoscopy in preventing delayed bleeding after endoscopic submucosal dissection of early gastric cancer.

Authors:  Zhiguo Guo; Lin Miao; Lijuan Chen; Hongsheng Hao; Yi Xin
Journal:  Exp Ther Med       Date:  2018-09-12       Impact factor: 2.447

6.  Continuous Use of Thienopyridine May Be as Safe as Low-Dose Aspirin in Endoscopic Resection of Gastric Tumors.

Authors:  Sooyeon Oh; Sang Gyun Kim; Jung Kim; Ji Min Choi; Joo Hyun Lim; Hyo-Joon Yang; Jae Yong Park; Seung Jun Han; Jue Lie Kim; Hyunsoo Chung; Hyun Chae Jung
Journal:  Gut Liver       Date:  2018-07-15       Impact factor: 4.519

7.  Bleeding After Gastric Endoscopic Submucosal Dissection Focused on Management of Xa Inhibitors.

Authors:  Shoko Ono; Masahiro Ieko; Ikko Tanaka; Yoshihiko Shimoda; Masayoshi Ono; Keiko Yamamoto; Naoya Sakamoto
Journal:  J Gastric Cancer       Date:  2022-02-23       Impact factor: 3.720

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.